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Summary
The present authors have been interested for many years in the possible
scientific utilization of plants in Asian, African and Latin-American countries for the
promotion of health, especially anti-parasitic effects of extracts from traditional
medicinal plants as shown in this report. Not a few areas are endemic with
infectious diseases in the countries, where excellent synthesized drugs are not
available because of their high prices for their living standard and difficulties in
public transportation. They cannot help utilizing traditional medicinal plants.
Among others much attention has been paid to parasites and medicinal plants in
Guatemala, Central America. The protozoal infection with Trypanosoma cruzi is
still nowadays one of the obstinate and intractable diseases there. This country is
rich in nature and traditional cultures including Spanish one. The inhabitants with
difficulties in purchasing modern synthesized medicine and in daily-life
transportation have so far utilized medicinal plants for their treatment of diseases.
No excellent drugs against T. cruzi have been developed because of rather a kind of
indifference by advanced scientists and drug companies to such kind of infectious
diseases in underdeveloped countries with few exceptions. It seems that there is a
way to overcome this situation by making the best of traditional herbs in endemic
areas and countries.
Encouraged by this idea, the present authors surveyed ethnobotanical and
bibliographical information, showing that about 300 species of plants native to
Central America are expected to be effective against any kinds of parasites.
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Through the process described below, candidate plants were chosen to be tested.
Trypanocidal studies have been carried out as follows.
First, the distribution of Chagas disease in Guatemala was described.
Second, extracts for screening were prepared for the assay.
Third, trypanocidal activity of the extracts was examined in vitro .
Forth, the trypanocidal effectiveness was tested using mice infected with T.
cruzi.
Fifth, anti-insect vector（triatomine）assay, pharmacological and toxicity tests
with analysis were mentioned.
And finally, the promising drugs are thought to be the extracts from
Neurolaena lobata and Tagetes lucida as a sound conclusion.
The other anti-parasitic efficacy and effectiveness for the promotion of health
have been studied using many kinds of plant-extracts from various coutries. These
assays have been carried out by the present authors in Japan as well as Guatemala as
shown in the text and tables in this paper.
要 約
世界を見回すと，今日でも住民たちが寄生虫に悩んでいる国と地域が多いの
に改めて驚く。その中には現在でも，かつての日本のように，寄生虫対策に
もっぱら伝承の生薬を用いているところもある。価格や輸送システム，その他
の地理的，政治的，経済的事情等の問題もあり，優良医薬品の入手が難しいの
かもしれない。しかも現地産生薬では実験科学的実証性を欠いており，それら
が真に効果を有するのか，又はあるとした場合どの程度のものなのか，はなは
だ覚束ない。
このように伝統的な生薬には改善すべき余地が残る。しかし本来の欠所を補
うことで現地産生薬の利用価値が一段と高まるはずだ。現在では優れた合成の
抗寄生虫薬が世界的に確立されつつあるが，それらに薬剤耐性の現われる可能
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性も低くない。したがって，そのような流行地の生薬に価値あるものを見出し
ておくことは地球市民全体にとって朗報となる。
現地産薬用植物に期待をかけて検討をおこなってきた本著者らは，史的に以
上のテーマを振り返ることで，今後の展望も含め考察する。とりわけ，中米グ
アテマラの例に注目する。同国では治療困難な寄生原虫症，シャーガス病（ク
ルーズトリパノゾーマ症）を始めとして種々の寄生虫が人々を苦しめてきた。
これらが原因で死の転帰をとることも珍しくない。
シャーガス病はグアテマラにおいて，基本的生活にも困難をきたしているよ
うな山間部村落を中心に広く分布するが，慢性疾患であることから，あまり顧
みられないことも珍しくない。現地産植物でひろく寄生虫に有効とされるもの
は，グアテマラなどの中央アメリカに300種近くもあることが筆者らの文献調
査でわかった。これらのアルコール抽出物の本虫に対する効果の検討を行う価
値があると考えられ，実践してきた。in vitro（試験管内）及び in vivo（感染
マウス）における試験で，ある程度期待出来る植物が見つかっている。
以上のように，中米グアテマラを舞台にした現地産薬用植物活用による感染
症対策において，同国と日本との間で共同研究の進捗がみられた。
薬用植物は合成化合物と並んで医療・健康増進に重要であることは言うまで
もない。このテーマで，著者らは長い間関心をいだき，それぞれの立場より研
究を進めてきた。今後とも海外と日本において地道な努力と各方面との共同体
制により，植物起源の優れた医薬品の開発を目指して研究を継続したい。
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Ⅰ．General Introduction, Materials and Methods
The present author et al. have been interested in biological, physiological and
biochemical activities of extracts from plants.1～41） Among them, a special emphasis
has been placed on the scientific utilization of plants in Asian, African and Latin-
American countries for the promotion of health, especially anti-parasitic
effectiveness of extracts from traditional medicinal plants.
For example, the protozoal infection with Trypanosoma cruzi is still nowadays
one of the obstinate and intractable diseases in Guatemala, Central America. The
present view is mostly based on the research in Guatemala2）＃1～77（Appendix 1）.
This is shown in the following II and III. The papers thought to be important are
repeatedly cited here in the present article.
The start of the present study in Guatemala was first discussed among the
present author et al. in the year of 1992, when the 500th anniversary of the
“discovery of America by Columbus”was celebrated. They have been thinking
over the possibility of opening a new era. Parasitic diseases have been controlled in
Guatemala, Central America. They had remembered what happened 500years
before.
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It is their dream that people can control the infectious diseases by new drugs
identified in plants, leading to the establishment of the good environment. This
would be a heritage for all the people.
Previous reports have proposed and discussed what a Guatemalan-Japanese
dream is.2） The dream is to overcome tropical diseases including intractable
parasitic diseases as Chagas disease with the modern science and technology
exploiting potential natural products. In the project they have started to devote
themselves to make this dream come true. They have just begun working for the
establishment of the basis for the control of incurable tropical diseases, especially
Chagas disease. However, there seem to be two approaches for the establishment.
One is by the pharmaceutical scientists specializing in medicinal plants and
pharmacognosy which makes plans to control tropical diseases. The other is by the
medicinal scientists and clinicians who intend to control the diseases by utilizing
natural products.
Maki and Caceres,2）majoring pharmaceutical sciences and tropical medicine,
especially medical parasitology have been expected to play a role in the experimental
treatment of Chagas disease. In the hope of realizing the Guatemalan-Japanese
dream in a desirable harmony of both sides, the present author et al. would like to
describe the2approaches in this research note. The approaches from the viewpoint
of pharmaceutical and medical sciences should go hand in hand still nowadays.
A bibliographical study has been carried out with special emphasis on papers
published by the present authors. Most of the descriptions in the text are based on
the information from the JICA Report in the Literature cited,2）＃1～77（Appendix1）
among which papers thought to be of importance to the present preliminary report
are directly indicated in the text.
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Ⅱ．Ethnobotanical studies with special emphasis on those
in Guatemala
Central America is the geographical and cultural region where the famous Maya
Empire flourished for several centuries. The influence of Atlantic and Pacific
Oceans with their rich lowland rainforest, and the high lands is noteworthy. These
represent the last portion of the Sierra Madre that is the determinant factor for the
biodiversity of the region. It includes more than100 different species per km2.
Since the opening of the New World to the colonial times, its richness and diversity
became evident. For this reason, several expeditions were sent to search, document
and collect the plants of medical importance in North and South America.
However, comparatively little was studied about it by the European naturalists.
The most important sources of the natural history of one of the Central American
countries, or Guatemala published in colonial times are the books by Fuentes
and Guzman（1932－33） and Ximenez（1967:“Historia Natural del Reino de
Guatemala”）cited in the JICA Report as2）＃33,76. Much the same or a similar
method is employed for the citation as below, though direct indications of authors
and their achievements are not always shown.
During the19th century several books and articles have been published about the
medicinal utilization of plants in Guatemala. However, unfortunately, botanical
identification is lacking in most of the cases. The main source that can be used for
establishing the materia medica in the Central-American region comprises the work
by Aguilar-Giron, and other researchers. Since1976, Caceres and his coworkers at
the Center for Central-American studies on Appropriate Technology have been
collecting information from the literature and ethnobotanical surveys on the plants
popularly used in Guatemala for the treatment of diseases. They have compared the
Maya medicine with Chinese one in an attempt to revalidate and transfer these
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therapeutic resources to rural areas（1980:“Informe del Primer Taller sobre
Botanica Medicinal Guatemalteca”）.
From the information so far obtained, the preliminary data bank on the
medicinal plants used by the population has been published. According to them, at
least623plants are utilized for the treatment of infectious diseases（1990: Caceres,
Giron & Freire : Plantas de uso medicinal en Guatemala, vol.1）. From these
areas, more than 200 plants have been studied to validate their anti-infective
effectiveness in vitro .
The result showed that about30％ of the properties could be demonstrated
in vitro . As listed in Table1, the important data on the effectiveness against the
Microorganisms targeted References（Literature cited）
Eumycetes or Fungi
（Dermatophytes）
2）＃17, or Caceres et al.（1991）J. Ethnopharmacol.31,
263－276
Eumycetes or Fungi
（Candida albicans）
2）＃13, or Caceres et al.（1987）J. Ethnopharmacol.20,
223－237;
2）＃16, or Caceres et al.（1991）J. Ethnopharmacol.20,
55－74
Pyogenic skin-bacteria 2）＃13, or Caceres et al.（1987）J. Ethnopharmacol.20,
223－237
Entero-bacteria 2）＃10, or Caceres et al.（1990）J. Ethnopharmacol.30,
55－73;2）＃19, or Caceres & Samayoa（1989）: DIGI-
USAC, Cuadernos de Investigacion No.6－89, Guatemaa,
P139）
Gram-positive bacteria
（Respiratory disorders）
2）＃9, or Caceres et al.（1991） J. Ethnopharmacol.31,
193－208
Gram-negative bacteria
（Vibrio cholera）
2）＃22, or Caceres et al.（1993）J. Ethnopharmacol.39,
73－75;2）31, or Espana et al.（1994） Fitoterapia 65,
273－274
Gram-negative bacteria
（Neisseria gonorrhoeae）
2）＃18, or Caceres et al.（1995）J. Ethnopharmacol.48,
85－88
Table1. Studies in Guatemala on effects of extracts from various plants on several
species of microorganisms※
※from JICA Report2）except for the information on T. cruzi . They have been published mostly in
Journal of Ethnopharmacology.
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following infectious pathogens are mostly included in Journal of
Ethnopharmacology.
Contrary to the information from Table3 listed below, few studies have been
carried out on the anti-parasitic effects of plant-origin drugs in Guatemala, except
the studies on the activity against one of the most important protozoal venereal
diseases, Trichomonas vaginalis infection（2）＃56, or Morales 1990） and the
roundworm Ascaris lumbricoides（2）＃57, or Morales1989in the JICA Report）.
In addition to the screening for the possible efficacy against these
microorganisms and infectious pathogens（Table1）, some pharmacological and
clinical studies have been carried out, particularly in the demonstration of the
following effectiveness.
●Diuretic effect :2）＃15, or Caceres et al.（1987） J. Ethnopharmacol.19,233－
245.
●Anti-inflammatory effect :2）＃15, or Caceres et al.（1987）J. Ethnopharmacol.
19,233－245;2）＃21, or Caceres et al.（1992） J. Ethonopharmacol.36,233－
237.
●Healing effect :2）＃8, or Caceres & Lopez（1991）Fitoterapia62,449－450.
●Anti-candial effect :2）＃35, or Giron et al.（1988）J. Ethonopharmacol.22,307
－313.
Although, the infrastructure and equipments in University of San Carlos
（USAC）, Guatemala have not been enough to carry out an ideal chemical
elucidation of active principles. In cooperation with researchers in University of
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Washington, USA, the chemical structures of the anti-fungal activity of Solanum
nigrescens（cited as2）＃74 in the JICA Report）and Brysonima crassiflolia（cited
as2）＃75in the JICA Report）have been demonstrated.
Briefly speaking, Guatemala located in the tropical zone is a mountainous
country. Several ecological and cultural circumstances coexist there to make the
country of tremendous interest for medical and pharmaceutical scientists.
One is that a wide variety of parasitic diseases including incurable ones
are rampant such as malaria, Chagas disease, Onchocerca volvulus and
Leishmaniasis［2）＃27, or Cosenza & Kroeger,1991 UNaH, P287;2）＃60, or
Orellana1987:“Indian Medicine in Highland Guatemala”P308）］.
The other is the abundance and diversity in medicinal plants which have been
traditionally used for maladies from the Maya times. Drugs from indigenous trees
and grasses play an important role still nowadays in the treatment of parasitic
infections among Guatemalan people. Such kind of drugs have advantages in their
supply, availability and the price.
However, there are some problems in utilization of crude drugs. Among the
first is the problem that a great part of the natural resources are being exhausted
quickly. The percentage of the area covered with forests has been much reduced
than before. Now the percentage in Guatemala is no more than50％, whereas it
was 90％ 50years ago. The urgent need in the present situation is the
domestication of useful medicinal plants so that they do not disappear for good.
At the same time lies one pivotal thing. Almost all the medicinal drugs have
hitherto been administered to patients based on empiricism or popular beliefs. With
the exception of quinine from Cinchona spp. as an antimalarial drug and ascaridol
from Chenopodium ambrosioides as anti-A. lumbricoides drug（2）＃71）, there is no
scientific evidence that supports the safety of the use of plant-origin drugs against
parasites. The efficacy of so-called medicinal drugs should be scientifically
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validated for the desirable and reasonable administration of the drugs to patients. It
goes without saying that no effective drugs should not be administered.
The scientific evaluation of plant-derived drugs in anti-parasitic effectiveness is
impossible without ethnobotanical information. The present authors（Maki &
Caceres,1993）surveyed the available ethnobotanical literatures.2） These describe
medicinal plants believed to be useful for the treatment of parasitic infections. This
report describes Central American plants of possible utility in the elimination of
parasites.
The ethnobotanical information has been collected on the possible medicinal
drugs popularly used in Central American region against parasites. At least280
species of plants were found to be used or believed to be effective against parasites
there.2） A detailed review was prepared in regard to scientific name, popular name,
parts used, spectrum of attributable activity against parasites such as ameba,
leishmanial, malaria, trichomonas, nematodes, trematodes and cestodes. It is hard
to describe the exact species of the parasites because most of the expelled worms are
recognized usually by inhabitants not parasitologists. And others are responsible for
elephantiasis, sarcoptidosis, myiasis and so on. Summing up, they are classified
into 3 categories. The first group is for the plants used for the treatment of
infections with protozoal parasites. The second group is for the plants used for the
purpose of expelling helminth parasites. And the third group is the plants used for
the other parasitic infections such as ecto-parasites.
These drugs which are believed to have anti-parasitic efficacy are worthy of
being examined in their scientific validity by comparison of experimental
（medicated）and control（non-medicated）groups. In this way the spectrum of the
effective crude drugs should be clarified. Some of the drugs may be turned out to
be non-effective, while others may be demonstrated to be as effective as modern
synthesized drugs or to exceed modern drugs. It is desirable to find plant-origin
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drugs or leading molecular structures which are better than modern medicine, not
only in their efficacy and spectrum, but also with less adverse effects. Modern
synthetic drugs are more or less inaccessible to the people in the rural regions and
their cost is high. If plant-origin drugs with high efficacy and without any severe
side effects are readily available to inhabitants living so remote from the towns, it
would be no exaggeration to say that it be the welfare and well-being for them.
Ⅲ．Trypanocidal studies in Guatemala
1．Endemicity of Chagas disease by Trypanosoma cruzi in Guatemala
Chagas disease is the common ailment in rural areas. It is restricted to the
New World, namely Continental America and a few Caribbean islands（cited in the
JICA Report as2）＃68）. Twenty-four million people are presumed to be infected
in the area. Depending the geographic area, most of the cases remain infected
during the life without developing any symptoms（cited in the JICA Report as2）＃
34,61）. The disease was first reported in Guatemala by Richenow（1932）.
During the period of1953 to1954, Renalver（cited in the JICA Report as2）＃63）
defined the endemic area which included6departments of the southeastern parts of
the country, describing the vectors of the disease（Rhodnius prolixus, Triatoma
dimidiate and T. nitida）and the rate of the house infestation（22～67％）. Since
1982, the Department of cyto-histology of the Faculty of Chemical Sciences and
Pharmacy, University of San Carlos, has been studying several aspects of the
disease. Two main lines of research have been conducted, one being on
epidemiology of the disease and the other on the transmission of intrauterine
infection.
Entomological and serological studies were conducted as epidemiological work.
The first study showed that15．9％ of the inhabitants in the endemic zone were
tested to be positive. In the second study, it was demonstrated that5％ of blood-
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bank donors were serologically positive. Particularly in Chiquimula,18．5％ of the
people showed a positive reaction. In the third study, no significant changes
occurred in samples from the endemic zones taken in1965（10．2％）and those
collected in the same villages in1986－87（10．8％）, although important changes in
housing facilities took place due to the earthquake which affected large parts of the
country in1976. The fourth study showed that the group of107 cardiac patients
from the endemic areas,46（43％）had positive antibody titers by 3 serologic
methods.
This disease is mostly endemic in South and Central American countries.
However, it is rather an orphan disease, since few studies to define the strategies for
the control have taken place in the region. JICA Project study started to take
measures in its control after demonstrating a number of patients suffering from this
infectious disease in Santa Maria Ixhuatan where most of the people live still
nowadays in mud houses.
Triatomes which burrow in the mud walls of the houses during the daytime and
emerge at night to feed on human blood, should be controlled in Ixhuatan for the
prevention of the people from further infection. At the same time patients should
be treated with suitable chemotherapeutics. At present, the drug of choice is
nifurtimox（Lampit）. This is available in Guatemala. This drug is said to be
highly toxic with a variety of side effects such as neuropathies, rash, gastro-
intestinal and psychiatric disturbances followed by anorexia and weight loss. Few
people are able to complete the long course of chemotherapy recommended for this
drug. In a recent review it is evident that few drugs against T. cruzi are being
experimented or used successfully, except for nifurtimox and allopurinol, though a
relatively large number of drugs against African trypanosomiasis and leishmaniasis
are reported（cited in the JICA Report as 2）＃72）. A promising drug is
allopurinol, a drug being developed on the theory of a selective toxicity. T. cruzi
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synthesize purines through salvage pathway, though mammalian hosts synthesize
them mainly de novo . This is where a selective toxicity is expected to generate.
Another possibility seems to be that the disease might be treated with extracts from
plants indigenous to Guatemala. In this country, many kinds of plants have been
believed to be effective for the curement of maladies and utilized among the
inhabitants as mentioned above.
For this reason, the authors have surveyed many literatures so as to find any
information on medicinal plants believed to be useful for patients with Chagas
disease. However, in vain, no information on them has been obtained so far. On
the other hand, about300plants have been listed to be effective against many kinds
of parasites.
2．Promising plants to be studied
There still remains the possibility that extracts effective against T. cruzi might
be discovered in other plants. However, the present authors, Maki & Caceres2）
have decided to start screening tests of the plants listed. Especially they are
interested in plants popularly used for malarial treatment. For the in vitro and in
vivo tests in anti-T. cruzi activity, the two plants, Tagetes lucica and Neurolaena
lobate were selected. These plants are explained in the JICA Report.2） However,
they are cited here briefly in Table2as follows.
Candidate1 Candidate2
Scientific name Tagetes lucida Neurolaena lobata
（Local name in
Guatemala）
（Pericon） （Tres puntas）
English name Sweet Marigold Jackass bitters
Japanese name Nioi-manjyu-giku An exact Japanese name is under
investigation.
Table2. Promising plants in Central America to be studied
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Height of the herb 30～90cm About3m
Notes on general
appearance and
morphological
characteristics of the
herb
This perennial herb is erect, high
with few branches and aromatic.
Dried materials are resinous and
gummy.
This is a kind of herb with the
stout, angled and hairy stem. It
has sometimes a few branches.
Leaf Leaves are of opposite type. These
are stemless and rather oblong.
Leaves are alternate, stemless, rather
oblong, and irregularly toothed.
Flower Yellow, the3rays are3mm long. Small and yellow without rays.
Seeds 6－7mm long, grooved with pappus
3－4mm long
Black,12．5mm long with whitish
pappus
Geographical
distribution
Areas from Mexico to Northern
Central America,1，000～2，000m
abve the sea level
Indigenous to thickets and waste
places from Yucatan to northern
Venezuela,0～1，500m above the
sea level
Traditional utilization
in Guatemala
It is said that decoction, infusion or
tincture of the leaves and flowers
have been used by local inhabitants
in Guatemala for the treatment of
spasmodic pains, diarrhea, gastritis,
malaria and rheumatism.
Reportedly, infusion of the leaves
have been used locally for pain,
nervous weakness, anemia, diabetes,
low blood pressure, malaria（studied
using murine malaria Plasmodium
berghei）and chronic ulcers.
Examples of the
major ingredients
and components
The leaves and and floweres are
abundant in essential oil （e. g.
limonene, anetol ）, alkaloids,
coumarins, flavonoids, glycocides,
leucoanthocyanines, saponins,
tannins, polyacetylene, tiophene
derivatives and acidic resins.
The leaves contain sesquiterpene
lactones, germacranolides（neurolein
B, lobatine A and lobatine B）,
many kinds of flavonoids such as
derivatives from quercetagetine,
kampherols and luteolines, and
thymol derivatives.
Efficacy studied Enterobacteria, gram-positive
bacteria and C. albicans
Carminative, diuretic, febrifuge,
spasmolytic and tonic
Pharmacology Depression of the central nervous
system, hypo-tensive activity and
efficacy against spasm were studied.
Hypoglucemic activity and possible
efficacy against Sarcoma
experimentally in mice and rats
were studied.
References cited in
the JICA Report
2）＃59,70,37,64,22,9,16,10,
19, 46, 62
2）＃59, 70, 25, 6, 37, 5, 39, 48
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3．Preparation of extracts for screening
The plant material was kindly provided by Farmaya Laboratory（Guatemala
City）, which had collected them from organically cultivated fields and shade-dried ;
voucher samples had been prepared for botanical confirmation and have been stored
in its herbarium for further references.
From each of the plant drugs three kinds of extracts were prepared in a medium
size percolator adapted by the present authors. The extract was obtained from
powdered dry material, first with10 volumes of CH2Cl2 and then with10 volumes
of EtOH by percolation at room temperature for24 hours. Another test material
was extracted from an equal amount of dry plant with water at65℃ by infusion
during24hours with agitation, followed by paper filtration.
The extract was concentrated first in a rotavapor under a reduced pressure and
with a temperature less than65℃, and then by the final desiccation dehumidification
in a drying chamber.
4．In vitro trypanocidal assay
Laboratory strain（Telahuen）is maintained in mice. It is cultivated in LIT
medium and diluted with fetal bovine serum to the trypomastigote density of2×105
parasites/ml. The in vitro trypanocidal activity is determined by the adaptation of
the techniques described by Cover & Gutteridge（1982: Trans. Roy. Soc. Trp. Med.
Hyg.76,633－635）
Trypanocidal activity is evaluated by the semi-quantitative method using an
inverted microscopy or counting in Neubauer chamber by comparison with culture
medium and allopurinol.
A completely randomized design is performed. Each assay is consist of
4 groups of 6 microplate wells. T. cruzi is inoculated in LIT medium. The
suspension contains3×106～6×106parasites/ml.
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The experimental and control groups are consist of the following No.1～4.
No.1: Six wells with T. cruzi in LIT medium, normal control for the growth
cycle of the parasite
No.2: Six wells with T. cruzi inoculated with allopurinol as a reference drug
No.3: Six wells with T. cruzi inoculated with250µg/ml of plant extract to be tested
No.4: Six wells with T. cruzi inoculated with750µg/ml of plant extract to be tested
The assay is measured with non-viable microorganism rate in each well48
hours after treatment administration. The wells should be preliminarily observed
one hour after the treatment administration to avoid any acute toxic effect.
The rate of non-viable microorganism is considered to be the anti-protozoan
activity. It is assumed that all the wells are under the same conditions before
treatment administration.
The use of the2concentrations of the plant extract is based on the fact that this
study is a screening of anti-protozoan activity. According to the previous papers on
preliminary tests, the dose-response curve showed the tendency of reaching a plateau
at high concentrations.
The suspensions of T. cruzi epimastigotes were donated by Department of
Protozoology, Institute for Tropical Medicine, Nagasaki University, Japan. A
mouse harbouring trypomastigotes was supplied by the coworkers, Drs. Vivian Matta
and Carlota Monroy. Trypomastigotes were collected from the blood of the mouse
killed by cervical dislocation. The suspension containing trypomastigotes was
centrifuged at1，200rpm to obtain the supernatant. This was then centrifuged again
at 3，000rmp. The resultant precipitation fraction was confirmed to contain
trypomastigotes under the microscope.
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5．In vivo trypanocidal assay
The methodology is an adaptation of previously described methods（cited in the
JICA Report as2）＃3,32 and52）. Twelve mice are inoculated with strains of T.
cruzi isolated in Guatemala. After24 hours,1g/kg of extract is administered by
the oral tube（nasogastric cannula）. The experiment includes controls to which
allopurinol in water is administered. A blood sample of0．5ml is obtained every
other day and parasitemia is quantitated microscopically. Survival rate after30days
is evaluated.
6．Anti-triatomine（vector of T. cruzi ）assay
This is also important for the comprehensive and integral approach towards the
struggle against vectors of Chagas disease.
The vector is cultivated by standard procedures. The activity is determined by
the topical application method described in the report. It is carried out in fourth
instar of the vector, Triatoma infestans nymphs in a randomized setting.
7．Pharmacological and toxicity tests with analysis
In addition to the assay of the extracts in trypanocidal activity carried
out in Guatemala, other pharmacological properties such as anti-microbial, anti-
inflammatory, diuretic, analgesic and spasmolytic ones, are worthy of investigation.
These are studied using rats. The acute toxicity is evaluated in mice by an
established procedure. These are followed by the chronic toxicity test, and
mutagenic and teratogenic studies. The results are analyzed by standard methods.
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Ⅳ．Studies on anti-parasitic and other efficacy of various plant-
extracts from Asian, African and Latin-American countries
1．Studies in Guatemala
The present authors have been interested in the scientific utilization of plants on
earth for the promotion of health as above mentioned. It is true that importance has
been attached to parasitic diseases so far. The present authors should promote the
research so that the studies might hopefully help to establish the basis for the control
of the incurable parasitic diseases in Guatemala and other countries.
So far the present authors have rather been concentrated in the study on
experimental chemotherapy of trypanosomiasis. Useful natural products are
interesting against other important parasites, namely, malaria, leishmaina,
Onchocerca volvulus and Taenia solium . These parasites would hopefully be
treated with extracts from medicinal plants in Guatemala and other countires.
Some natural products might be effective also for the treatment of virus
infections, for instance that of dengue fever. To prevent inhabitants from these
infections, it is important to control the vectors which bring the parasites. Such
natural products that would be useful, available by the people, at low cost and
without any severe side effects should be identified.
Based on lines of ethnobotanical information, medicinal plants should be
scientifically examined in the efficacy against a wide variety of what are responsible
for tropical or parasitic diseases mentioned above. When effective drugs are
discovered in the laboratory, an immunological study is necessary so that the
immune-diagnosis might help to judge the cure and prognosis of infected animals.
The other desirable activity is a cooperative study. It is of great concern to the
present authors that medicinal plants of established effectiveness in a scientific way
are utilized by rural people. A close survey should be necessary from the viewpoint
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of human ecology. It is regrettable that the Guatemalan nature including useful
medicinal plants is threatened and even being exhausted as mentioned above. The
present authors heartily wish that human ecological studies might play an important
role in stopping this sad tendency. We have to preserve this heritage for the
coming generations.
2．Studies in Japan
It is pivotal to find useful plant-origin drugs against not only tropical and
parasitic diseases but also other infectious diseases such as those caused by the
bacteria and the virus（Table3）. In Japan, for instances, the components of the
medicinal plant Angelica shikokiana have been found to have anti-HIV activity.33）
Alkaline extracts from Sasa senanensis, and the pine-seed shell have been
Parasites targeted（classification） Literatures cited in this paper
Brugia pahangi（nematode） ★9～14）,24）
Angiostrongylus cantonensis（nematode） 8）and a preliminary paper※
Trichinella spiralis（nematode） 8）
Trichuris muris（nematode） 17）,21）
Hymenolepis nana（cestode） 1）,25）,35）
Schistosoma japonicum（trematode） 29）
Trichomonas vaginalis（protozoa） 7）
Trypanosoma cruzi（protozoa） 22）except for the studies in Guatemala
Table3. Studies in Japan on effects of extracts from various plants on several species of
parasites except for those shown in JICA Report2）
★A series of the studies was started with the non-medicinal-plant substances listed as follows.
Aoki, Y., Fujimaki, Y., Mitsui, Y., Kimura, E. & Maki, J. : Experimental studies on filariases :
in vitro effects of substances on the movement and microfilarial production by adult Brugia
pahangi（in Japanese）Proceedings of Cooperative studies in Institute for Tropical Medicine,
Nagasaki University（“糸状虫症の化学療法に関する研究”’94，長崎大学熱帯医学研究所『共
同研究報告集』）42－46（1994）
※A preliminary study was carried out to show in vitro efficacy of Mexican-plant extracts against A.
cantonensis. Maki et al.（2003）: Research Journal of Fukuoka University1, 193－197.
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demonostrated to have a biological activity such as prominent antiviral one.30～32）
Sakagami et al.（1999）34） found that substances with only 2％ of orally
administered high molecular weight lignin-carbohydrate complex（LCC） are
incorporated into the blood, demonstrating the low bioavailability. In thought of
this fact, in vivo tests of such kind of substances are worthy of their further
investigation in the possible effects on pathogens, though it is essential to establish
the most effective administration route and drug-delivery system.
Abe et al.（1989）35） found an important fact. Pre-treatment with lignin-
carbohydrate complex（LCC） from the pine cone of Pinus parviflora（Sieb. et
Zucc.）protected infant mice from Hymenolepis nana（cestode）infection, though the
mechanism was undefined. The anti-parasite activity of LCC exceeded that of
neutral polysaccharide of pine-cone extract（Fr.Ⅰ andⅡ）, low molecular weight
glucan（Schizophyllan）, water-insoluble glucan purified from Alcaligenes faecalis
var. myxogene IFO13140（TAK）and the carboxyl methyl glucan of TAK（CM-
TAK）, suggesting the involvement of lignin structure for the expression of anti-
parasite activity.
Since LCC activated the gene expression of dectin-2, mannose recetor,36） any
stimulation of this receptor may also be contributing in the expression of anti-
parasite activity.
Limited digestion experiments demonstrated that antiviral activity was derived
from lignin portion（＝phenylpropenoid polymers）, but not that of carbohydrate.37）
This was confirmed by the papers using synthetic lignin that does not contain
carbohydrate showed slightly higher anti-influenza virus activity38） and anti-HIV
activity.39，40）
Highly polymerized tannis showed some anti-HIV activity but not so potent as
LCC, whereas condensed tannins and flavonoids were essentially inactive.41）
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Ⅴ．A tentative conclusion
The present authors have been interested for many years in the possible
scientific utilization of plants in Asian, African and Latin-American countries for the
promotion of health, especially anti-parasitic effects of extracts from traditional
medicinal plants as shown in this report. They do not believe that their goal and
dream can come true without the global cooperative work. Their efforts should
always be made fresh and motivated. The continuation should be with the balance
between the tradition and the modernization before an ideal completion.
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